New Recruiting Trial: Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease
WHY IT MATTERS
This is the first clinical trial testing focused ultrasound specifically for Huntington's disease pallidal treatment, offering patients a potentially non-invasive alternative to traditional deep brain stimulation surgery.
Researchers are testing a new treatment called low-intensity focused ultrasound that aims to help people with Huntington's disease by targeting a specific part of the brain called the pallidum. This non-invasive technique uses sound waves instead of surgery to potentially reduce movement problems and other symptoms. The trial is just starting in April 2026 and is looking for patients to participate.
NCT ID: NCT07513844 Title: Optimizing Parameters of Low-Intensity Focused Ultrasound for Pallidal Modulation in Huntington's Disease Status: RECRUITING Phase: NA Sponsor: First Affiliated Hospital of Fujian Medical University Start date: 2026-04-20 URL: https://clinicaltrials.gov/study/NCT07513844 Source: UniteRare clinical trials database